CA2971197A1 - Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes - Google Patents
Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes Download PDFInfo
- Publication number
- CA2971197A1 CA2971197A1 CA2971197A CA2971197A CA2971197A1 CA 2971197 A1 CA2971197 A1 CA 2971197A1 CA 2971197 A CA2971197 A CA 2971197A CA 2971197 A CA2971197 A CA 2971197A CA 2971197 A1 CA2971197 A1 CA 2971197A1
- Authority
- CA
- Canada
- Prior art keywords
- composition
- thc
- cbd
- skin
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/348—Cannabaceae
- A61K36/3482—Cannabis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2971197A CA2971197A1 (fr) | 2017-06-20 | 2017-06-20 | Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2971197A CA2971197A1 (fr) | 2017-06-20 | 2017-06-20 | Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2971197A1 true CA2971197A1 (fr) | 2018-12-20 |
Family
ID=64755018
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2971197A Abandoned CA2971197A1 (fr) | 2017-06-20 | 2017-06-20 | Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2971197A1 (fr) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019144189A1 (fr) * | 2018-01-24 | 2019-08-01 | Botanix Pharmaceuticals Ltd | Régime de dosage de cannabinoïde pour l'acné |
| WO2019144191A1 (fr) * | 2018-01-24 | 2019-08-01 | Botanix Pharmaceuticals Ltd | Régime de dosage de cannabinoïde pour le psoriasis |
| WO2019144190A1 (fr) * | 2018-01-24 | 2019-08-01 | Botanix Pharmaceuticals Ltd | Régime de dosage de cannabinoïde pour dermatite et affections cutanées inflammatoires |
| IT202000017137A1 (it) * | 2020-07-15 | 2022-01-15 | Linnea Sa | Estratti di cannabis sativa e loro usi |
| CN114340604A (zh) * | 2019-06-26 | 2022-04-12 | 康宝动物治疗有限公司 | Cbd组合物 |
| WO2022128390A1 (fr) | 2020-12-14 | 2022-06-23 | Symrise Ag | Compositions cosmétiques et/ou pharmaceutiques contenant des cannabinoïdes |
| CN114901071A (zh) * | 2019-11-08 | 2022-08-12 | 维拉生物科技有限公司 | 外周作用的含有大麻二酚(cbd)的组合物及其用于增强女性性功能或治疗女性性障碍的用途 |
| EP4079301A2 (fr) | 2021-04-19 | 2022-10-26 | Symrise AG | Compositions comprenant du cannabidiol et, éventuellement, du bisabolol |
| WO2023280636A1 (fr) * | 2021-07-05 | 2023-01-12 | TULICHEM GmbH | Produit de soin et de protection de la peau, et de désinfection de plaies, toléré par la peau, à appliquer sur la peau |
-
2017
- 2017-06-20 CA CA2971197A patent/CA2971197A1/fr not_active Abandoned
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019144191A1 (fr) * | 2018-01-24 | 2019-08-01 | Botanix Pharmaceuticals Ltd | Régime de dosage de cannabinoïde pour le psoriasis |
| WO2019144190A1 (fr) * | 2018-01-24 | 2019-08-01 | Botanix Pharmaceuticals Ltd | Régime de dosage de cannabinoïde pour dermatite et affections cutanées inflammatoires |
| WO2019144189A1 (fr) * | 2018-01-24 | 2019-08-01 | Botanix Pharmaceuticals Ltd | Régime de dosage de cannabinoïde pour l'acné |
| US11896560B2 (en) | 2018-01-24 | 2024-02-13 | Botanix Pharmaceuticals Ltd. | Cannabinoid dosing regime for dermatitis and inflammatory skin conditions |
| CN114340604A (zh) * | 2019-06-26 | 2022-04-12 | 康宝动物治疗有限公司 | Cbd组合物 |
| CN114901071A (zh) * | 2019-11-08 | 2022-08-12 | 维拉生物科技有限公司 | 外周作用的含有大麻二酚(cbd)的组合物及其用于增强女性性功能或治疗女性性障碍的用途 |
| JP2023535313A (ja) * | 2020-07-15 | 2023-08-17 | リネア・ソチエタ・アノニマ | アサ(Cannabis sativa)抽出物およびその使用 |
| IT202000017137A1 (it) * | 2020-07-15 | 2022-01-15 | Linnea Sa | Estratti di cannabis sativa e loro usi |
| WO2022013736A1 (fr) * | 2020-07-15 | 2022-01-20 | Linnea Sa | Extraits de cannabis sativa et leurs utilisations |
| WO2022128390A1 (fr) | 2020-12-14 | 2022-06-23 | Symrise Ag | Compositions cosmétiques et/ou pharmaceutiques contenant des cannabinoïdes |
| WO2022223099A1 (fr) | 2021-04-19 | 2022-10-27 | Symrise Ag | Compositions comprenant du cannabidiol et, éventuellement, du bisabolol |
| EP4079301A2 (fr) | 2021-04-19 | 2022-10-26 | Symrise AG | Compositions comprenant du cannabidiol et, éventuellement, du bisabolol |
| WO2023280636A1 (fr) * | 2021-07-05 | 2023-01-12 | TULICHEM GmbH | Produit de soin et de protection de la peau, et de désinfection de plaies, toléré par la peau, à appliquer sur la peau |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10603301B2 (en) | Cannabis-based extracts and topical formulations for use in skin disorders | |
| CA2971197A1 (fr) | Extraits de cannabis et formulations topiques destines a une utilisation pour des problemes cutanes | |
| Hou et al. | Sea buckthorn (Hippophaë rhamnoides L.) oil improves atopic dermatitis-like skin lesions via inhibition of NF-κB and STAT1 activation | |
| Meng et al. | Psoriasis therapy by Chinese medicine and modern agents | |
| RU2671492C2 (ru) | Композиции, содержащие берберин или его аналоги для лечения кожных заболеваний, связанных с розацеа или с покраснением лица | |
| CA2823086C (fr) | Extraits vegetaux pour le traitement et la prevention d'infections | |
| Xie et al. | Eucommia ulmoides Oliv. bark aqueous extract inhibits osteoarthritis in a rat model of osteoarthritis | |
| Wang et al. | Inhibitory effect of gallic acid on CCl4-mediated liver fibrosis in mice | |
| Wang et al. | Huanglian ointment alleviates eczema by maintaining the balance of c-Jun and JunB and inhibiting AGE-RAGE-mediated pro-inflammation signaling pathway | |
| Liu et al. | Angelica Yinzi alleviates 1-chloro-2, 4-dinitrobenzene-induced atopic dermatitis by inhibiting activation of NLRP3 inflammasome and down-regulating the MAPKs/NF-kB signaling pathway | |
| Wu et al. | Effects of topical application of a tri-herb formula on inflammatory dry-skin condition in mice with oxazolone-induced atopic dermatitis | |
| Wang et al. | Ameliorative effects of sea buckthorn oil on DNCB induced atopic dermatitis model mice via regulation the balance of Th1/Th2 | |
| Abali et al. | Efficacy of acupuncture on pain mechanisms, inflammatory responses, and wound healing in the acute phase of major burns: an experimental study on rats | |
| Milani et al. | Cariniana domestica fruit peels present topical anti-inflammatory efficacy in a mouse model of skin inflammation | |
| Pan et al. | Wu-Zi-Yan-Zong-Wan protects mouse blood-testis barrier from Tripterygium wilfordii Hook. f. multiglycoside-induced disruption by regulating proinflammatory cytokines | |
| Yu et al. | Yuhong ointment ameliorates inflammatory responses and wound healing in scalded mice | |
| Martínez et al. | Reporting a fatality during tumescent liposuction | |
| Li et al. | Arctiin Alleviates Atopic Dermatitis Against Inflammation and Pyroptosis Through Suppressing TLR4/MyD88/NF-κB and NLRP3/Caspase-1/GSDMD Signaling Pathways | |
| Wu et al. | Inhibitory effects of isoliquiritin on an atopic dermatitis model through the CD177/JAK2/STAT pathway in vitro and in vivo | |
| Meng et al. | Qing-Re-Chu-shi decoction ameliorates 2, 4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice through anti-inflammation and immunoregulatory mechanisms | |
| EP3417856A1 (fr) | Formulations topiques cannabis-based extraits et destinés à être utilisés dans des affections cutanées | |
| Peng et al. | Anti-inflammatory and immunomodulatory effects of polysaccharide extracted from Wuguchong (maggot) on 2, 4-dinitrochlorobenzene-induced atopic dermatitis in mice | |
| Jo et al. | Ameliorative and synergic effects of derma-H, a new herbal formula, on allergic contact dermatitis | |
| de Almeida-Junior et al. | Anti-inflammatory and antinociceptive effects of kaempferide from the Brazilian green propolis | |
| Zhu et al. | Xiaoyin-anshen formula alleviates psoriasis complicated by sleep disturbances by regulating melatonin, antioxidant enzymes, and pro-inflammatory cytokines in mice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20221221 |
|
| FZDE | Discontinued |
Effective date: 20221221 |